Cargando…

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer

Epithelial ovarian cancer is by far the most lethal gynecological malignancy. The exploration of promising immunomarkers to predict prognosis in ovarian cancer patients remains challenging. In our research, we carried out an integrated bioinformatic analysis of genome expressions and their immune ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chanyuan, Deng, Ting, Cao, Junya, Zhou, Yun, Luo, Xiaolin, Feng, Yanling, Huang, He, Liu, Jihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047357/ https://www.ncbi.nlm.nih.gov/pubmed/36980477 http://dx.doi.org/10.3390/diagnostics13061169

Ejemplares similares

Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma
por: Liang, Qiuli, et al.
Publicado: (2021)

Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy
por: He, Wenting, et al.
Publicado: (2023)

Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma
por: Xie, Haixiang, et al.
Publicado: (2023)

GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer
por: Feng, Yanling, et al.
Publicado: (2015)

ITGB1 as a prognostic biomarker correlated with immune suppression in gastric cancer
por: Gu, Wenchao, et al.
Publicado: (2022)

The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
por: Zhu, Tingting, et al.
Publicado: (2020)

ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer
por: Wu, Pancheng, et al.
Publicado: (2019)

ITGB4 as a novel serum diagnosis biomarker and potential therapeutic target for colorectal cancer
por: Jiang, Xia, et al.
Publicado: (2021)

Single-Exosome Profiling Identifies ITGB3+ and ITGAM+ Exosome Subpopulations as Promising Early Diagnostic Biomarkers and Therapeutic Targets for Colorectal Cancer
por: Guo, Wei, et al.
Publicado: (2023)

The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer
por: Deng, Ting, et al.
Publicado: (2021)

Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

ITGB4 is a novel prognostic factor in colon cancer
por: Li, Meng, et al.
Publicado: (2019)

Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
por: Dai, Danian, et al.
Publicado: (2021)

Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia
por: Wei, Jie, et al.
Publicado: (2021)

Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma
por: Damanakis, Alexander I., et al.
Publicado: (2022)

Identifying Mitotic Kinesins as Potential Prognostic Biomarkers in Ovarian Cancer Using Bioinformatic Analyses
por: Liu, Hailun, et al.
Publicado: (2022)

Proteomic analysis identified potential age‐associated prognostic biomarkers in pneumonia‐derived paediatric sepsis
por: Luo, Ting, et al.
Publicado: (2021)

TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients
por: He, Guolin, et al.
Publicado: (2020)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Shear-Induced ITGB4 Promotes Endothelial Cell Inflammation and Atherosclerosis
por: Kong, Xiangquan, et al.
Publicado: (2022)

LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2
por: Liu, Mengyao, et al.
Publicado: (2018)

miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
por: Cui, Yajie, et al.
Publicado: (2018)

Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG)
por: Liu, He, et al.
Publicado: (2023)

A SMYD3/ITGB6/TGFβ1 Positive Feedback Loop Promotes the Invasion and Adhesion of Ovarian Cancer Spheroids
por: Jiang, Yahui, et al.
Publicado: (2021)

Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
por: Jiang, Shan, et al.
Publicado: (2023)

Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis
por: Li, Liubing, et al.
Publicado: (2017)

Integrative Analyses Identify Osteopontin, LAMB3 and ITGB1 as Critical Pro-Metastatic Genes for Lung Cancer
por: Wang, Xiao-Min, et al.
Publicado: (2013)

The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma
por: Chen, Shuo, et al.
Publicado: (2017)

Prognostic and Safety Roles in Laparoscopic Versus Abdominal Radical Hysterectomy in Cervical Cancer: A Meta-analysis
por: Cao, Tiefeng, et al.
Publicado: (2015)

Screening and prognostic value of potential biomarkers for ovarian cancer
por: Li, Huiqin, et al.
Publicado: (2021)

Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis
por: Hu, Yongzheng, et al.
Publicado: (2023)

Prognostic value of prostaglandin I2 synthase and its correlation with tumor-infiltrating immune cells in lung cancer, ovarian cancer, and gastric cancer
por: Dai, Danian, et al.
Publicado: (2020)

CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype
por: Li, Han, et al.
Publicado: (2022)

EccDNA-oriented ITGB7 expression in breast cancer
por: Yang, Lin, et al.
Publicado: (2022)

A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer
por: Zhu, Huijun, et al.
Publicado: (2021)

Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients
por: He, Jing, et al.
Publicado: (2018)

Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer
por: An, Xi-Zhou, et al.
Publicado: (2016)

Identification of potential biomarkers in ovarian carcinoma and an evaluation of their prognostic value
por: Cai, Junyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lv7ghl3vmsoc018elr0jqmnqnn